BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 12871026)

  • 21. Clinical features and management of cyanide poisoning.
    Holland MA; Kozlowski LM
    Clin Pharm; 1986 Sep; 5(9):737-41. PubMed ID: 3530615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel, orally effective cyanide antidotes.
    Nagasawa HT; Goon DJ; Crankshaw DL; Vince R; Patterson SE
    J Med Chem; 2007 Dec; 50(26):6462-4. PubMed ID: 18038966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The "rhodanese" fold and catalytic mechanism of 3-mercaptopyruvate sulfurtransferases: crystal structure of SseA from Escherichia coli.
    Spallarossa A; Forlani F; Carpen A; Armirotti A; Pagani S; Bolognesi M; Bordo D
    J Mol Biol; 2004 Jan; 335(2):583-93. PubMed ID: 14672665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of intramuscularly administered cyanide antidotes on methemoglobin formation and survival.
    Vick JA; Von Bredow JD
    J Appl Toxicol; 1996; 16(6):509-16. PubMed ID: 8956097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enzyme therapy in cyanide poisoning: effect of rhodanese and sulfur compounds.
    Frankenberg L
    Arch Toxicol; 1980 Oct; 45(4):315-23. PubMed ID: 6934715
    [No Abstract]   [Full Text] [Related]  

  • 26. Antagonism of cyanide intoxication with murine carrier erythrocytes containing bovine rhodanese and sodium thiosulfate.
    Cannon EP; Leung P; Hawkins A; Petrikovics I; DeLoach J; Way JL
    J Toxicol Environ Health; 1994 Mar; 41(3):267-74. PubMed ID: 8126749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of cyanide intoxication on hepatic rhodanese kinetics.
    Buzaleh AM; Vazquez ES; Batlle AM
    Gen Pharmacol; 1990; 21(2):219-22. PubMed ID: 2332141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regional and subcellular distribution of cyanide metabolizing enzymes in the central nervous system.
    Mimori Y; Nakamura S; Kameyama M
    J Neurochem; 1984 Aug; 43(2):540-5. PubMed ID: 6588145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo studies on rhodanese encapsulation in mouse carrier erythrocytes.
    Leung P; Cannon EP; Petrikovics I; Hawkins A; Way JL
    Toxicol Appl Pharmacol; 1991 Sep; 110(2):268-74. PubMed ID: 1891774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 3-Mercaptopyruvate sulfurtransferase: rapid equilibrium-ordered mechanism with cyanide as the acceptor substrate.
    Jarabak R; Westley J
    Biochemistry; 1980 Mar; 19(5):900-4. PubMed ID: 6928374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sulfanegen sodium treatment in a rabbit model of sub-lethal cyanide toxicity.
    Brenner M; Kim JG; Lee J; Mahon SB; Lemor D; Ahdout R; Boss GR; Blackledge W; Jann L; Nagasawa HT; Patterson SE
    Toxicol Appl Pharmacol; 2010 Nov; 248(3):269-76. PubMed ID: 20705081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SseA, a 3-mercaptopyruvate sulfurtransferase from Escherichia coli: crystallization and preliminary crystallographic data.
    Spallarossa A; Carpen A; Forlani F; Pagani S; Bolognesi M; Bordo D
    Acta Crystallogr D Biol Crystallogr; 2003 Jan; 59(Pt 1):168-70. PubMed ID: 12499560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Encapsulation of thiosulfate: cyanide sulfurtransferase by mouse erythrocytes.
    Leung P; Ray LE; Sander C; Way JL; Sylvester DM; Way JL
    Toxicol Appl Pharmacol; 1986 Mar; 83(1):101-7. PubMed ID: 3456651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The mercaptopyruvate pathway in cysteine catabolism: a physiologic role and related disease of the multifunctional 3-mercaptopyruvate sulfurtransferase.
    Nagahara N; Sawada N
    Curr Med Chem; 2006; 13(10):1219-30. PubMed ID: 16719781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modifiers of mercaptopyruvate sulfurtransferase catalyzed conversion of cyanide to thiocyanate in vitro.
    Wing DA; Baskin SI
    J Biochem Toxicol; 1992; 7(2):65-72. PubMed ID: 1404244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of sulfanegen for mass cyanide casualties.
    Patterson SE; Moeller B; Nagasawa HT; Vince R; Crankshaw DL; Briggs J; Stutelberg MW; Vinnakota CV; Logue BA
    Ann N Y Acad Sci; 2016 Jun; 1374(1):202-9. PubMed ID: 27308865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sodium nitroprusside-induced cyanide intoxication and prevention with sodium thiosulfate prophylaxis.
    Hall VA; Guest JM
    Am J Crit Care; 1992 Sep; 1(2):19-25; quiz 26-7. PubMed ID: 1307887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A combination of rhodanese and ethanethiosulfonate as an antidote in experimental cyanide poisoning.
    CLEMEDSON CJ; HULTMAN HI; SORBO B
    Acta Physiol Scand; 1955 Dec; 35(1):31-5. PubMed ID: 13301846
    [No Abstract]   [Full Text] [Related]  

  • 39. Properties of the Escherichia coli rhodanese-like protein SseA: contribution of the active-site residue Ser240 to sulfur donor recognition.
    Colnaghi R; Cassinelli G; Drummond M; Forlani F; Pagani S
    FEBS Lett; 2001 Jul; 500(3):153-6. PubMed ID: 11445076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Sodium thiosulfate for acute cyanide poisoning: study in a rat model].
    Renard C; Borron SW; Renaudeau C; Baud FJ
    Ann Pharm Fr; 2005 Mar; 63(2):154-61. PubMed ID: 15976683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.